MENU
+Compare
REPL
Stock ticker: NASDAQ
AS OF
Aug 29 closing price
Price
$5.40
Change
+$0.02 (+0.37%)
Capitalization
421.5M

REPL Replimune Group Forecast, Technical & Fundamental Analysis

Replimune Group Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for REPL with price predictions
Aug 29, 2025

REPL in downward trend: 10-day moving average moved below 50-day moving average on July 25, 2025

The 10-day moving average for REPL crossed bearishly below the 50-day moving average on July 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where REPL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on REPL as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REPL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where REPL's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for REPL just turned positive on August 12, 2025. Looking at past instances where REPL's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REPL advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.252) is normal, around the industry mean (19.821). P/E Ratio (0.000) is within average values for comparable stocks, (52.034). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.591). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (302.560).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. REPL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REPL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

REPL is expected to report earnings to fall 22.01% to -74 cents per share on November 18

Replimune Group REPL Stock Earnings Reports
Q3'25
Est.
$-0.74
Q2'25
Missed
by $0.11
Q1'25
Missed
by $2.35
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.14
The last earnings report on August 07 showed earnings per share of -94 cents, missing the estimate of -84 cents. With 2.26M shares outstanding, the current market capitalization sits at 421.50M.
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HQIVX22.240.02
+0.09%
Hartford Equity Income R6
QDVSX19.27-0.06
-0.31%
FI Instl ESG Stck Fd for Ret Plns
PVIVX52.76-0.31
-0.58%
Paradigm Micro-Cap
EVSRX26.75-0.20
-0.74%
Allspring Disciplined US Core R6
DTCCX15.56-0.13
-0.83%
BNY Mellon Sust US Equity C

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
+0.37%
IMNN - REPL
56%
Loosely correlated
-1.66%
SNDX - REPL
49%
Loosely correlated
+0.06%
KYMR - REPL
46%
Loosely correlated
-1.32%
ERAS - REPL
44%
Loosely correlated
N/A
BEAM - REPL
43%
Loosely correlated
-2.91%
More